Working to Have a Normal Life With Cystic Fibrosis in an Adherence-Driven Health Care System

References

1. 1.↵
   1. Stephenson AL,
   2. Stanojevic S,
   3. Sykes J,
   4. Burgel PR

   . The changing epidemiology and demography of cystic fibrosis. Presse Med 2017;46(6):e87–e95.

   OpenUrl
2. 2.↵
   1. Sawicki GS,
   2. Sellers DE,
   3. Robinson WM

   . High treatment burden in adults with cystic fibrosis: Challenges to disease self-management. J Cyst Fibros 2009;8(2):91–96.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Eakin MN,
   2. Bilderback A,
   3. Boyle MP,
   4. Mogayzel PJ,
   5. Riekert KA

   . Longitudinal association between medication adherence and lung health in people with cystic fibrosis. J CystFibros 2011;10(4):258–264.

   OpenUrl
4. 4.↵
   1. Conway SP,
   2. Pond MN,
   3. Hamnett T,
   4. Watson A

   . Compliance with treatment in adult patients with cystic fibrosis. Thorax 1996;51(1):29–33.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Arias Llorente RP,
   2. Bousoño García C,
   3. Díaz Martín JJ

   . Treatment compliance in children and adults with Cystic Fibrosis. J Cyst Fibros 2008;7(5):359–367.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Quittner AL,
   2. Zhang J,
   3. Marynchenko M,
   4. Chopra PA,
   5. Signorovitch J,
   6. Yushkina Y,
   7. Riekert KA

   . Pulmonary medication adherence and health-care use in cystic fibrosis. Chest 2014;146(1):142–151.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Siracusa CM,
   2. Ryan J,
   3. Burns L,
   4. Wang Y,
   5. Zhang N,
   6. Clancy JP,
   7. Drotar D

   . Electronic monitoring reveals highly variable adherence patterns in patients prescribed ivacaftor. J Cyst Fibros 2015;14(5):547–548.

   OpenUrl
8. 8.↵
   1. Ajzen I

   . The theory of planned behavior. Organ Behav Hum Decis Process 1991;50(2):179–211.

   OpenUrlCrossRefWeb of Science
9. 9.
   1. Hochbaum GM

   . Public participation in medical screening programs: a socio-psychological study. Washington, DC: U.S. Department of Health, Education and Welfare; 1958.
10. 10.
    1. Baum A,
    2. Singer J

    1. Leventhal H,
    2. Nerenz D,
    3. Steele DJ

    . Illness representations and coping with Health threats. In: Baum A, Singer J, editors. A handbook of psychology and health. Hillsdale, NJ: Erlbaum; 1984. p. 219–252.
11. 11.
    1. Orem DE,
    2. Taylor SG,
    3. Renpenning KM

    . Nursing : concepts of practice. 6th ed. St. Louis, MO; Toronto, CA: Mosby; 2001.
12. 12.↵
    1. Parcel GS,
    2. Swank PR,
    3. Mariotto MJ,
    4. Bartholomew LK,
    5. Czyzewski DI,
    6. Sockrider MM,
    7. et al

    . Self-management of cystic fibrosis: A structural model for educational and behavioral variables. Soc Sci Med 1994;39(9):1307–1315.

    OpenUrl
13. 13.↵
    1. Conn VS,
    2. Enriquez M,
    3. Ruppar TM,
    4. Chan KC

    . Meta-analyses of theory use in medication adherence intervention research. Am J Health Behav 2016;40(2):155–171.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Holmes EAF,
    2. Hughes DA,
    3. Morrison VL

    . Predicting adherence to medications using health psychology theories: A systematic review of 20 years of empirical research. Value Heal 2014;17(8):863–876.

    OpenUrl
15. 15.↵
    1. Greenop D,
    2. Glenn S,
    3. Ledson M,
    4. Walshaw M

    . Self-care and cystic fibrosis: A review of research with adults. Heal Soc Care Community 2010;18(6):653–661.

    OpenUrl
16. 16.↵
    1. Castellani C,
    2. Duff AJA,
    3. Bell SC,
    4. Heijerman HGM,
    5. Munck A,
    6. Ratjen F,
    7. et al

    . ECFS best practice guidelines: the 2018 revision. J Cyst Fibros 2018;17(2):153–178.

    OpenUrl
17. 17.↵
    1. Charmaz K

    . Constructing grounded theory: a practical guide through qualitative analysis. Thousand Oaks, CA: Sage 2006.
18. 18.↵
    1. Blumer H

    . The Methodological Position of Symbolic Interactionism. In: Symbolic Interactionism: Perspective and Method. Englewood Cliffs, NJ: Prentice-Hall; 1969.
19. 19.↵
    1. Magee GA,
    2. Magee GA

    . Hegel and the hermetic tradition. Ithaca, NY: Cornell University Press; 2001.
20. 20.↵
    1. Popkin RH,
    2. Stroll A

    . Philosophy made simple. New York, NY: Doubleday; 1993.
21. 21.↵
    1. Bregnballe V,
    2. Schiøtz PO,
    3. Lomborg K

    . Parenting adolescents with cystic fibrosis: The adolescents' and young adults' perspectives. Patient Prefer Adherence 2011;5:563–570.

    OpenUrlPubMedWeb of Science
22. 22.↵
    1. George M,
    2. Rand-Giovannetti D,
    3. Eakin MN,
    4. Borrelli B,
    5. Zettler M,
    6. Riekert KA

    . Perceptions of barriers and facilitators: Self-management decisions by older adolescents and adults with CF. J Cyst Fibros 2010;9(6):425–432.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Macdonald M,
    2. Martin-Misener R,
    3. Helwig M,
    4. Smith LJ,
    5. Godfrey CM,
    6. Curran J,
    7. Murphy A

    . Experiences of adults with cystic fibrosis in adhering to medication regimens: a qualitative systematic review. JBI database Syst Rev Implement reports 2016;14(5):258–285.

    OpenUrl
24. 24.↵
    1. Whiting P,
    2. Al Maiwenn,
    3. Burgers L,
    4. Westwood M,
    5. Ryder S,
    6. Hoogendoorn M,
    7. et al

    . Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: A systematic review and cost-effectiveness analysis. Health Technol Assess (Rockv) 2014;18(18):1–106.

    OpenUrlCrossRef
25. 25.↵
    1. Armstrong MJ,
    2. Mullins CD,
    3. Gronseth GS,
    4. Gagliardi AR

    . Impact of patient involvement on clinical practice guideline development: a parallel group study. Implementation Science 2018;13:55.

    OpenUrl